NCT05604521: A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI |
|
|
| Terminated | 1 | 31 | US | PfSPZ Vaccine, PfSPZ Challenge (7G8), Normal Saline, Placebo | Sanaria Inc., University of Maryland, Baltimore, National Institute of Allergy and Infectious Diseases (NIAID) | Malaria, Malaria,Falciparum | 09/23 | 09/23 | | |